An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
De Pergola G, Nitti A, Bartolomeo N, Gesuita A, Giagulli VA, Triggiani V, Guastamacchia E, Silvestris F.De Pergola G, et al.Biomed Res Int. 2013;2013:921348. doi: 10.1155/2013/921348. Epub 2013 Jan 14.Biomed Res Int. 2013.PMID: 23509804Free PMC article.
De Pergola G, Tartagni M, Bartolomeo N, Bruno I, Masiello M, Caccavo D, Bavaro S, Silvestris F.De Pergola G, et al.Endocr Metab Immune Disord Drug Targets. 2013 Dec;13(4):301-5. doi: 10.2174/1871530314666140116111542.Endocr Metab Immune Disord Drug Targets. 2013.PMID: 24428680
De Pergola G, Nardecchia A, Cirillo M, Boninfante B, Sciaraffia M, Giagulli VA, Triggiani V, Silvestris F.De Pergola G, et al.Endocr Metab Immune Disord Drug Targets. 2015;15(4):297-301. doi: 10.2174/1871530315666150506125651.Endocr Metab Immune Disord Drug Targets. 2015.PMID: 25944063
De Pergola G, Triggiani V, Bartolomeo N, Nardecchia A, Giagulli VA, Bruno I, Caccavo D, Silvestris F.De Pergola G, et al.Endocr Metab Immune Disord Drug Targets. 2016;16(4):270-275. doi: 10.2174/1871530317666170106150756.Endocr Metab Immune Disord Drug Targets. 2016.PMID: 28059033
De Pergola G, Giagulli VA, Bartolomeo N, Gaeta F, Petruzzella A, Guastamacchia E, Triggiani V, Silvestris F.De Pergola G, et al.Endocr Metab Immune Disord Drug Targets. 2017;17(3):207-212. doi: 10.2174/1871530317666170825164415.Endocr Metab Immune Disord Drug Targets. 2017.PMID: 28847266
De Pergola G, Triggiani V, Bartolomeo N, Giagulli VA, Anelli M, Masiello M, Candita V, De Bellis D, Silvestris F.De Pergola G, et al. Among authors: de bellis d.Endocr Metab Immune Disord Drug Targets. 2018;18(6):646-652. doi: 10.2174/1871530318666180406163426.Endocr Metab Immune Disord Drug Targets. 2018.PMID: 29623823